These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1842231)

  • 1. Heme arginate (Normosang) in the treatment of attacks of acute hepatic porphyrias.
    Kostrzewska E; Gregor A; Tarczyńska-Nosal S
    Mater Med Pol; 1991; 23(4):259-62. PubMed ID: 1842231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute attacks of hepatic porphyria: specific treatment with heme arginate].
    Nordmann Y; Deybach JC
    Ann Med Interne (Paris); 1993; 144(3):165-7. PubMed ID: 8368699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute porphyria: treatment with heme.
    Tenhunen R; Mustajoki P
    Semin Liver Dis; 1998; 18(1):53-5. PubMed ID: 9516678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early administration of heme arginate for acute porphyric attacks.
    Mustajoki P; Nordmann Y
    Arch Intern Med; 1993 Sep; 153(17):2004-8. PubMed ID: 8357285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute intermittent porphyria. The first use of Heme-arginate in Czechoslovakia].
    Kordac V; Martásek P
    Cas Lek Cesk; 1987 Jul; 126(30):944-7. PubMed ID: 3652151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatic porphyrias and drugs].
    Deybach JC; Puy H; Nordmann Y
    Gastroenterol Clin Biol; 1994; 18(4):348-53. PubMed ID: 7958651
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neurological complications of acute intermittent porphyria precipitated by porphyrinogenic drugs and efficiency of heme-arginate treatment].
    Akopova-Larbi R; Ben Youssef TI; Gargouri A; Kraoua I; Gouider R; Gouider-Khouja N
    Tunis Med; 2009 Sep; 87(9):621-6. PubMed ID: 20180386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria.
    Dover SB; Moore MR; Fitzsimmons EJ; Graham A; McColl KE
    Gastroenterology; 1993 Aug; 105(2):500-6. PubMed ID: 8335204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between uroporphyrin excretion, acute attacks of hereditary coproporphyria and successful treatment with haem arginate.
    Schoenfeld N; Mamet R; Dotan I; Sztern M; Levo Y; Aderka D
    Clin Sci (Lond); 1995 Mar; 88(3):365-9. PubMed ID: 7736708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of haem arginate in acute hepatic porphyria.
    Herrick AL; McColl KE; Moore MR; Cook A; Goldberg A
    Lancet; 1989 Jun; 1(8650):1295-7. PubMed ID: 2566827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration.
    Kordac V; Kozáková M; Martásek P
    Ann Med; 1989 Aug; 21(4):273-6. PubMed ID: 2551350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers].
    Tasnádi G; Bor M; Pusztai A
    Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haem arginate in acute hepatic porphyrias.
    Kordac V; Martásek P
    Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1098. PubMed ID: 3094787
    [No Abstract]   [Full Text] [Related]  

  • 15. Haem arginate as effective maintenance therapy for hereditary coproporphyria.
    Ma E; Mar V; Varigos G; Nicoll A; Ross G
    Australas J Dermatol; 2011 May; 52(2):135-8. PubMed ID: 21605099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three cases of acute porphyria-experience with heme therapy in one case.
    Bhootra K; Bhootra RK
    J Assoc Physicians India; 1995 Apr; 43(4):303-4. PubMed ID: 8713283
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical manifestations and diagnosis of acute porphyria].
    Pustovoĭt IaS; Pivnik AV; Karpova IV
    Ter Arkh; 1999; 71(7):76-80. PubMed ID: 10481873
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with haematin in acute hepatic porphyria.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    Q J Med; 1981; 50(198):161-74. PubMed ID: 7302116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of haem arginate on variegate porphyria.
    Timonen K; Mustajoki P; Tenhunen R; Lauharanta J
    Br J Dermatol; 1990 Sep; 123(3):381-7. PubMed ID: 2206975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypeptide levels increase during acute onset of hepatic porphyrias.
    Medenica R; Lazovic G; Huschart T; Mukerjee S; Long P; Corbitt W; Powell D
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):9-27. PubMed ID: 9074785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.